ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
3D 바이오프린팅 시장의 규모는 최근, 비약적으로 확대하고 있습니다. 2025년 21억 9,000만 달러에서 2026년에는 27억 달러로, CAGR 23.0%로 성장이 전망되고 있습니다. 지금까지의 성장세는 바이오메디컬 연구 자금 증가, in vitro 약물 시험 모델에 대한 수요 증가, 재생의료의 조기 도입, 세포배양 기술의 발전, 의료 분야에서의 3D 프린팅 활용 확대 등이 요인으로 꼽힙니다.
3D 바이오프린팅 시장 규모는 향후 수년간 급격한 성장이 전망됩니다. 2030년에는 62억 1,000만 달러에 달하며, CAGR은 23.2%에 달할 전망입니다. 예측 기간의 성장 요인으로는 맞춤형 의료의 확대, 장기 이식 수요 증가, 바이오프린팅 조직에 대한 규제적 지원, 바이오의약품 연구 파이프라인의 확대, 확장 가능한 바이오프린팅 플랫폼의 발전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 재생 의료를 위한 조직 공학, 환자 맞춤형 임플란트 제조, 첨단 바이오 잉크 제형 개발, 고해상도 멀티 매트리얼 바이오프린팅, 인쇄된 조직의 임상 적용 등이 있습니다.
만성질환 증가는 향후 3D 바이오프린팅 시장의 성장을 촉진하는 요인이 될 것으로 예측됩니다. 만성질환은 보통 3개월 이상, 경우에 따라는 평생 지속되는 질환으로, 조직 모델 제작, 만성질환 연구 지원, 잠재적 장기 대체요법의 실현을 위해 3D 바이오프린팅 기술의 활용이 확대되고 있습니다. 예를 들어 유엔 전문기구인 세계보건기구(WHO)에 따르면 2024년 2월 기준으로 2025년 신규 암 발병 건수가 3,500만 건을 넘어설 것으로 예상되며, 이는 2022년 추정치인 2,000만 건보다 77% 증가한 수치입니다. 따라서 만성질환의 급증은 3D 바이오프린팅 시장의 성장을 촉진하는 중요한 요인입니다.
3D 바이오프린팅 시장의 주요 기업은 조직공학 및 재생의료의 정확성과 효율성을 향상시키기 위해 3D 바이오프린터와 같은 혁신적인 기술 솔루션 개발에 주력하고 있습니다. 3D 바이오 프린터는 살아있는 세포를 포함한 바이오 잉크를 사용하여 의학 연구 및 재생의료용 3차원 조직-장기 구조물을 제작하는 장치입니다. 예를 들어 2024년 6월, 미국에 본사를 둔 세라믹 분말 및 금속 폴리머 제품 개발 기업인 Teton 3D는 Bison Bio DLP 3D 바이오 프린터를 발표하며 바이오프린팅 시장에 진출했습니다. 칼리마와 공동 개발한 이 첨단 프린터는 구축 크기 조절이 가능하며(30×20mm, 57×32mm, 96×54mm), 생체 조직 바이오프린팅에 필수적인 테톤의 독자적인 LAP 광개시제 및 GelMA 하이드로겔 바이오잉크와 호환이 가능합니다. 크기 24×24×24×24인치(약 61×61×61cm), 무게 75파운드(약 34kg)의 바이슨 바이오는 1만9,950달러에 판매되고 있으며, 복잡한 조직과 장기를 생성할 수 있게 함으로써 의료 분야의 진보를 촉진하고 맞춤형 의료와 재생의학을 지원하는 것을 목표로 하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
3D Bioprinting, a form of additive manufacturing, involves the layer-by-layer printing of live structures that emulate the behavior of living systems. This process utilizes cells and biocompatible materials, commonly referred to as bio-inks. The primary application of 3D bioprinting materials is in drug research, and more recently, in the creation of cell scaffolds for repairing damaged ligaments and joints.
The key components in 3D bioprinting include 3D bioprinters and bio-inks. 3D bioprinters employ three-dimensional technology along with biocompatible materials to replicate various body parts, facilitating the bioprinting of tissues, bones, organs, blood vessels, and biomedical components. The materials involved in the process encompass living cells, hydrogels, extracellular matrices, and others. The application of 3D bioprinting extends to research and clinical settings, among others, and finds implementation in diverse sectors such as research organizations, academic institutes, biopharmaceutical companies, hospitals, and more.
Tariffs are impacting the 3D bioprinting market by increasing the cost of imported bioprinters, precision components, and specialized bioink raw materials, disrupting global supply chains and slowing procurement cycles. Research applications, clinical applications, and bioink manufacturing segments are most affected, with regions such as asia-pacific, china, and europe facing higher production and equipment acquisition costs due to their dependence on cross-border technology and material sourcing. Despite these challenges, tariffs are encouraging manufacturers to localize production, strengthen domestic supply chains, and invest in regional bioprinting infrastructure, which is gradually supporting long-term market resilience and innovation.
The 3D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinting market statistics, including 3D bioprinting industry global market size, regional shares, competitors with a 3D bioprinting market share, detailed 3D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinting industry. This 3D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The 3D bioprinting market size has grown exponentially in recent years. It will grow from $2.19 billion in 2025 to $2.7 billion in 2026 at a compound annual growth rate (CAGR) of 23.0%. The growth in the historic period can be attributed to growth in biomedical research funding, rising demand for in vitro drug testing models, early adoption of regenerative medicine, advances in cell culture technologies, increasing use of 3D printing in healthcare.
The 3D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $6.21 billion in 2030 at a compound annual growth rate (CAGR) of 23.2%. The growth in the forecast period can be attributed to expansion of personalized medicine, increasing organ transplantation demand, regulatory support for bioprinted tissues, growth in biopharmaceutical research pipelines, advancements in scalable bioprinting platforms. Major trends in the forecast period include tissue engineering for regenerative therapies, patient-specific implant fabrication, advanced bioink formulation development, high-resolution multi-material bioprinting, clinical translation of printed tissues.
The anticipated rise in chronic diseases is set to be a driving factor in the prospective growth of the 3D bioprinting market. Chronic diseases, persisting over extended periods-typically three months or more, and often for a person's lifetime-have increasingly utilized 3D bioprinting for creating tissue models, aiding in chronic disease research and potential organ replacement therapies. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, in 2025, over 35 million new cancer cases are predicted, a 77% increase from the estimated 20 million cases in 2022. Consequently, the upsurge in chronic diseases is a significant driver behind the growth of the 3D bioprinting market.
Major companies in the 3D bioprinting market are focusing on developing innovative technological solutions, such as 3D bioprinters, to improve precision and efficiency in tissue engineering and regenerative medicine. 3D bioprinters are devices that utilize bioinks containing living cells to produce three-dimensional tissue and organ structures for medical research and regenerative medicine applications. For example, in June 2024, Tethon 3D, a US-based developer of ceramic powder and metal-polymer products, introduced the Bison Bio DLP 3D bioprinter, marking its entry into the bioprinting market. Developed in collaboration with Carima, this advanced printer offers adjustable build sizes (30 X 20 mm, 57 X 32 mm, and 96 X 54 mm) and is compatible with Tethon's proprietary LAP photoinitiator and GelMA hydrogel bioink, crucial for bioprinting living tissues. Measuring 24 X 24 X 24 inches and weighing 75 lbs, the Bison Bio is priced at $19,950 and aims to drive advancements in healthcare by enabling the creation of complex tissues and organs for biomedical research, supporting personalized medicine and regenerative therapies
In February 2025, Eli Lilly and Company acquired Organovo's FXR program, including its lead asset FXR314, for an upfront payment of USD 10 million plus milestone-based payments. The acquisition enables Lilly to leverage Organovo's 3D-bioprinted human tissue models to generate predictive preclinical data, accelerating FXR314 development and reducing clinical risk. Organovo's expertise in 3D-bioprinted tissue models supports more efficient drug discovery and testing. This strategic move strengthens Lilly's pipeline in metabolic and liver-targeted therapies while reflecting a broader industry trend of integrating advanced bioprinting technologies to optimize drug development.
Major companies operating in the 3d bioprinting market are Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., Cyfuse Biomedical KK, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, 3D Biotek LLC, 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., 3D Systems Corporation, EnvisionTEC GmbH, GE HealthCare Technologies Inc., Nuclera Nucleics Ltd.
North America was the largest region in the 3D bioprinting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3D bioprinting market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the 3D bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The 3D bioprinting market consists of sales of extrusion-based bioprinting, inkjet-based bioprinting, laser-assisted bioprinting, and stereolithography bioprinting. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
3D Bioprinting Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses 3d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for 3d bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d bioprinting market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Component: 3D Bioprinters; Bioinks
2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Other Materials
3) By Application: Research Applications; Clinical Application; Other Applications
4) By End User: Research Organization And Academic Institutes; Biopharmaceutical Companies; Hospitals; Other End Users
Subsegments:
1) By 3D Bioprinters: Inkjet 3D Bioprinters; Microextrusion 3D Bioprinters; Laser-Assisted 3D Bioprinters; Stereolithography (SLA) Bioprinters
2) By Bioinks: Natural Bioinks; Synthetic Bioinks; Hybrid Bioinks
Companies Mentioned: Organovo Holdings Inc.; Allevi Inc.; Cellink AB; Aspect Biosystems Ltd.; Cyfuse Biomedical KK; Poietis SA; TeVido BioDevices; Nano3D Biosciences Inc.; RegenHU Ltd.; GeSiM mbH; Advanced Solutions Life Sciences LLC; Regenovo Biotechnology Co. Ltd.; Regemat 3D S.L.; Bio3D Technologies; ROKIT Healthcare Co. Ltd.; Inventia Life Science Pvt. Ltd.; Vivax Bio LLC; 3D Biotek LLC; 3D Bio Corp; 3D Bioprinting Solutions; BICO Group AB; CollPlant Biotechnologies Ltd.; 3D Systems Corporation; EnvisionTEC GmbH; GE HealthCare Technologies Inc.; Nuclera Nucleics Ltd.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
2.4. Global 3D Bioprinting Market Attractiveness Scoring And Analysis
2.4.1. Overview of Market Attractiveness Framework
2.4.2. Quantitative Scoring Methodology
2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations
3. 3D Bioprinting Market Supply Chain Analysis
3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users
4. Global 3D Bioprinting Market Trends And Strategies
4.1. Key Technologies & Future Trends
4.1.1 Biotechnology, Genomics And Precision Medicine
4.1.2 Industry 4.0 And Intelligent Manufacturing
4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
4.1.4 Artificial Intelligence And Autonomous Intelligence
4.1.5 Sustainability, Climate Tech And Circular Economy
4.2. Major Trends
4.2.1 Tissue Engineering For Regenerative Therapies
4.2.2 Patient-Specific Implant Fabrication
4.2.3 Advanced Bioink Formulation Development
4.2.4 High-Resolution Multi-Material Bioprinting
4.2.5 Clinical Translation Of Printed Tissues
5. 3D Bioprinting Market Analysis Of End Use Industries
5.1 Research Organizations And Academic Institutes
5.2 Biopharmaceutical Companies
5.3 Hospitals
5.4 Contract Research Organizations
5.5 Regenerative Medicine Centers
6. 3D Bioprinting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global 3D Bioprinting Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global 3D Bioprinting PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global 3D Bioprinting Market Size, Comparisons And Growth Rate Analysis
7.3. Global 3D Bioprinting Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global 3D Bioprinting Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global 3D Bioprinting Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. 3D Bioprinting Market Segmentation
9.1. Global 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
3D Bioprinters, Bioinks
9.2. Global 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Living Cells, Hydrogels, Extracellular Matrices, Other Materials
9.3. Global 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Research Applications, Clinical Application, Other Applications
9.4. Global 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Research Organization And Academic Institutes, Biopharmaceutical Companies, Hospitals, Other End Users
9.5. Global 3D Bioprinting Market, Sub-Segmentation Of 3D Bioprinters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inkjet 3D Bioprinters, Microextrusion 3D Bioprinters, Laser-Assisted 3D Bioprinters, Stereolithography (SLA) Bioprinters
9.6. Global 3D Bioprinting Market, Sub-Segmentation Of Bioinks, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. 3D Bioprinting Market Regional And Country Analysis
10.1. Global 3D Bioprinting Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global 3D Bioprinting Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific 3D Bioprinting Market
11.1. Asia-Pacific 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China 3D Bioprinting Market
12.1. China 3D Bioprinting Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India 3D Bioprinting Market
13.1. India 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan 3D Bioprinting Market
14.1. Japan 3D Bioprinting Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia 3D Bioprinting Market
15.1. Australia 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia 3D Bioprinting Market
16.1. Indonesia 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea 3D Bioprinting Market
17.1. South Korea 3D Bioprinting Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan 3D Bioprinting Market
18.1. Taiwan 3D Bioprinting Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia 3D Bioprinting Market
19.1. South East Asia 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe 3D Bioprinting Market
20.1. Western Europe 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK 3D Bioprinting Market
21.1. UK 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany 3D Bioprinting Market
22.1. Germany 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France 3D Bioprinting Market
23.1. France 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy 3D Bioprinting Market
24.1. Italy 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain 3D Bioprinting Market
25.1. Spain 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe 3D Bioprinting Market
26.1. Eastern Europe 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia 3D Bioprinting Market
27.1. Russia 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America 3D Bioprinting Market
28.1. North America 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA 3D Bioprinting Market
29.1. USA 3D Bioprinting Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada 3D Bioprinting Market
30.1. Canada 3D Bioprinting Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America 3D Bioprinting Market
31.1. South America 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil 3D Bioprinting Market
32.1. Brazil 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East 3D Bioprinting Market
33.1. Middle East 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa 3D Bioprinting Market
34.1. Africa 3D Bioprinting Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa 3D Bioprinting Market, Segmentation By Component, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. 3D Bioprinting Market Regulatory and Investment Landscape
36. 3D Bioprinting Market Competitive Landscape And Company Profiles
36.1. 3D Bioprinting Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. 3D Bioprinting Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. 3D Bioprinting Market Company Profiles
36.3.1. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Allevi Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Cellink AB Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Cyfuse Biomedical KK Overview, Products and Services, Strategy and Financial Analysis
37. 3D Bioprinting Market Other Major And Innovative Companies
Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, 3D Biotek LLC, 3D Bio Corp, 3D Bioprinting Solutions
38. Global 3D Bioprinting Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The 3D Bioprinting Market
40. 3D Bioprinting Market High Potential Countries, Segments and Strategies
40.1 3D Bioprinting Market In 2030 - Countries Offering Most New Opportunities
40.2 3D Bioprinting Market In 2030 - Segments Offering Most New Opportunities
40.3 3D Bioprinting Market In 2030 - Growth Strategies
